CJC-1295 (without DAC) + IPA

CJC-1295 No DAC / Ipamorelin is a synthetic peptide research blend commonly studied in laboratory models involving receptor signaling, peptide interaction, and endocrine pathway characterization.

This blend combines CJC-1295 No DAC, a modified growth hormone-releasing hormone analog, with Ipamorelin, a ghrelin receptor-related peptide. In controlled research settings, the combination may be evaluated for its role in receptor activity, signaling response, and assay development.

Product Details

Format: Lyophilized powder

Available Size: 10 mg

Composition: CJC-1295 No DAC + Ipamorelin

Appearance: Powder in a sealed research vial

Purity: >98% when verified by applicable third-party testing/COA

Research Focus Areas

Receptor Signaling:

Used in research models involving GHRH-related and ghrelin receptor-related pathway activity.

Peptide Interaction Studies:

May be evaluated in laboratory settings where dual-peptide signaling behavior is being studied.

Assay Development: Commonly used in non-clinical research for method development, calibration, and pathway characterization.

Endocrine Pathway Models:

Studied in controlled experimental systems related to peptide-mediated signaling and cellular response.

Research Use Only

This product is sold for research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Storage: Keep lyophilized powder cool/dry. Refrigerate after reconstitution.